Beijing Hotgen Biotech (SHA:688068) recently obtained 35 overseas qualification certifications, according to a Tuesday filing with the Shanghai bourse.
These certifications cover a range of diagnostic reagents and equipment as well as biochemical tests mainly in the European Union, Indonesia and Cambodia.
Shares of the in vitro diagnostic device manufacturer closed 3% lower Tuesday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.